2
H index
0
i10 index
18
Citations
Lionel Perrier : Citation Profile
Université de Lyon | RESEARCH PRODUCTION: 4 Articles 105 Papers RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
16 years (2002 - 2018). Relations with other researchers
Works with:
Authors registered in RePEc who have co-authored more than one work in the last five years with Lionel Perrier. | Is cited by:
| Cites to:
|
Main data
Where Lionel Perrier has published?
| Journals with more than one article published | # docs |
|---|---|
| Health Policy | 2 |
| Working Papers Series with more than one paper published | # docs |
|---|---|
| Post-Print / HAL | 95 |
| Working Papers / Groupe d'Analyse et de Thorie Economique Lyon St-tienne (GATE Lyon St-tienne), Universit de Lyon | 6 |
| Working Papers / HAL | 4 |
Recent works citing Lionel Perrier (2022 and 2021)
| Year | Title of citing document |
|---|
Works by Lionel Perrier:
| Year | Title | Type | Cited |
|---|---|---|---|
| 2009 | Transférabilité des évaluations de coûts en santé. Analyse des facteurs de variabilité In: Revue économique. [Full Text][Citation analysis] | article | 0 |
| 2009 | Transférabilité des évaluations de coûts en santé : analyse des facteurs de variabilité.(2009) In: Post-Print. [Citation analysis] This paper has another version. Agregated cites: 0 | paper | |
| 2015 | A literature review to identify factors that determine policies for influenza vaccination In: Health Policy. [Full Text][Citation analysis] | article | 6 |
| 2015 | A literature review to identify factors that determine policies for influenza vaccination.(2015) In: Post-Print. [Citation analysis] This paper has another version. Agregated cites: 6 | paper | |
| 2016 | Influenza vaccination policy-making processes in France and The Netherlands: Framework and determinants In: Health Policy. [Full Text][Citation analysis] | article | 2 |
| 2016 | Influenza vaccination policy-making processes in France and The Netherlands: Framework and determinants.(2016) In: Post-Print. [Citation analysis] This paper has another version. Agregated cites: 2 | paper | |
| 2008 | Les évaluations de coûts en santé sont-elles transférables ? In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2008 | Les évaluations de coûts en santé sont-elles transférables ?.(2008) In: Post-Print. [Full Text][Citation analysis] This paper has another version. Agregated cites: 0 | paper | |
| 2008 | Short-Term cost impact of compliance with clinical practice guidelines for initial sarcoma treatment In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2008 | Short-Term cost impact of compliance with clinical practice guidelines for initial sarcoma treatment.(2008) In: Post-Print. [Full Text][Citation analysis] This paper has another version. Agregated cites: 0 | paper | |
| 2009 | The effect of health care expenditures on survival in locally advanced and metastatic Non Small Cell Lung Cancer In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2009 | The effect of health care expenditures on survival in locally advanced and metastatic Non Small Cell Lung Cancer.(2009) In: Post-Print. [Full Text][Citation analysis] This paper has another version. Agregated cites: 0 | paper | |
| 2013 | Literature review of the decision-making determinants related to the influenza vaccination policy In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2013 | Literature review of the decision-?making determinants related to the influenza vaccination policy.(2013) In: Working Papers. [Full Text][Citation analysis] This paper has another version. Agregated cites: 0 | paper | |
| 2014 | Inégalités d’exposition aux agents cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel en France In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2014 | Inégalités dexposition aux agents cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel en France.(2014) In: Working Papers. [Full Text][Citation analysis] This paper has another version. Agregated cites: 0 | paper | |
| 2016 | Counterfactual approach with survival or time to event outcomes: An application to an exhaustive cohort of Epithelial Ovarian Carcinoma in the Rhône-Alps region of France In: Working Papers. [Full Text][Citation analysis] | paper | 0 |
| 2016 | Counterfactual approach with survival or time to event outcomes: An application to an exhaustive cohort of Epithelial Ovarian Carcinoma in the Rhône-Alps region of France.(2016) In: Working Papers. [Full Text][Citation analysis] This paper has another version. Agregated cites: 0 | paper | |
| 2017 | Toxicité et qualité de vie comparées après curiethérapie par iode 125 et radiothérapie stéréotaxique des cancers prostatiques [Toxicity and quality of life comparison of iodine 125 brachytherapy and s In: Post-Print. [Citation analysis] | paper | 0 |
| 2004 | Light ion facility projects in Europe: methodological aspects for the calculation of the treatment cost per protocol In: Post-Print. [Citation analysis] | paper | 0 |
| 2005 | Trajectoires optimales des patients évoluant vers la dépendance In: Post-Print. [Citation analysis] | paper | 0 |
| 2007 | The impact of CD34+ cell dose on the cost of HDT with PBSC transplantation in lymphomia In: Post-Print. [Citation analysis] | paper | 0 |
| 2005 | A model to calculate treatment cost per protocol for light ion facility radiotherapy projects in Europe In: Post-Print. [Citation analysis] | paper | 0 |
| 2007 | Assessing the generalisability of cost evaluation results using the euclidean metric and principal components analysis : Lesson from a high-cost innovation in oncology In: Post-Print. [Citation analysis] | paper | 0 |
| 2005 | Report of work package 6 “Health economics aspects” In: Post-Print. [Citation analysis] | paper | 0 |
| 2006 | The contribution of the simulation for innovative technologies: The case of the hadrontherapy In: Post-Print. [Citation analysis] | paper | 0 |
| 2007 | Les évaluations de coûts en santé sont-elles transférables ? Mesures et application à une innovation très coûteuse en cancérologie In: Post-Print. [Citation analysis] | paper | 0 |
| 2007 | Organisation et financement des soins : vers une inadéquation croissante ? In: Post-Print. [Citation analysis] | paper | 0 |
| 2004 | Cost comparison of two surgical strategies in the treatment of breast cancer: Sentinel lymph node biopsy versus axillary lymph node dissection In: Post-Print. [Citation analysis] | paper | 0 |
| 2002 | Vers une nécessaire harmonisation des évaluations de coûts en santé. Lexemple des intensifications thérapeutiques avec autogreffes de cellules souches du sang périphérique en France In: Post-Print. [Citation analysis] | paper | 0 |
| 2008 | A Decision-making Tool for a Costly Innovative Technology: The Case of Carbon Ion Radiotherapy In: Post-Print. [Citation analysis] | paper | 0 |
| 2009 | Cost-effectiveness analysis of compliance with clinical guidelines for sarcoma management In: Post-Print. [Citation analysis] | paper | 0 |
| 2010 | Apports de lévaluation économique et de lanalyse dimpact budgétaire pour la décision publique en santé : lexemple du cancer du sein In: Post-Print. [Citation analysis] | paper | 0 |
| 2010 | Cost-effectiveness analysis: methods and applications in oncology In: Post-Print. [Citation analysis] | paper | 0 |
| 2011 | Costi del tratamento In: Post-Print. [Citation analysis] | paper | 0 |
| 2011 | Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma In: Post-Print. [Citation analysis] | paper | 0 |
| 2013 | Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma.(2013) In: Post-Print. [Citation analysis] This paper has another version. Agregated cites: 0 | paper | |
| 2013 | Cost Effectiveness of Pegfilgrastim Versus Filgrastim After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Lymphoma and Myeloma.(2013) In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] This paper has another version. Agregated cites: 0 | article | |
| 2011 | Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in adult patients with lymphoma and myeloma: cost-effectiveness evaluation alongside a randomized In: Post-Print. [Citation analysis] | paper | 0 |
| 2010 | Impact of chemotherapy prescriptions and costs on survival in advanced or metastatic NSCLC: a single-institution study using an instrumental variables approach In: Post-Print. [Citation analysis] | paper | 0 |
| 2011 | Adherence to practice guidelines for the management of patients with sarcoma: A cost-effectiveness assessment in two European regions In: Post-Print. [Citation analysis] | paper | 0 |
| 2011 | Conformity with clinical practice guidelines for management of patients with sarcoma: a cost-effectiveness assessment in two European regions In: Post-Print. [Citation analysis] | paper | 0 |
| 2011 | Apports de lévaluation médico-économique pour la décision publique en santé In: Post-Print. [Citation analysis] | paper | 0 |
| 2012 | A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study) In: Post-Print. [Citation analysis] | paper | 1 |
| 2012 | The use of economic evaluations in health decision-making at the macro level: a literature review In: Post-Print. [Citation analysis] | paper | 1 |
| 2012 | Evaluation économique prospective de la radiothérapie guidée par limage des cancers de la prostate dans le cadre du programme national de Soutien aux Thérapeutiques Innovantes et Coûteuses In: Post-Print. [Citation analysis] | paper | 0 |
| 2012 | Discordant diagnoses in sarcoma, GIST and desmoide tumour in France: results from the network RREPS In: Post-Print. [Citation analysis] | paper | 0 |
| 2012 | Cluster analysis and principal component analysis to access the variability of data in cost evaluations: methods and applications in oncology In: Post-Print. [Citation analysis] | paper | 0 |
| 2012 | A cost-analysis of image-guided radiation therapy (IGRT) in prostate cancer: results from a phase III clinical trial In: Post-Print. [Citation analysis] | paper | 0 |
| 2012 | Cost-effectiveness analysis: an interdisciplinary research and methodological perspective In: Post-Print. [Citation analysis] | paper | 0 |
| 2013 | Cost of prostate image-guided radiation therapy: Results of a randomized trial In: Post-Print. [Citation analysis] | paper | 1 |
| 2013 | Cost of physical activity intervention during adjuvant chemotherapy in breast cancer: results of the randomized trial PASAPAS In: Post-Print. [Citation analysis] | paper | 0 |
| 2013 | Curiethérapie : valorisation et aspects médico-économiques In: Post-Print. [Citation analysis] | paper | 0 |
| 2013 | Design of a randomised controlled trial of adapted physical activity during adjuvant treatment for localised breast cancer: the PASAPAS feasibility study In: Post-Print. [Citation analysis] | paper | 0 |
| 2013 | Comprendre les analyses médico-économiques : intervention didactique à lintention des cliniciens In: Post-Print. [Citation analysis] | paper | 0 |
| 2013 | A cost-analysis of stereotactic radiotherapy in lung cancer In: Post-Print. [Citation analysis] | paper | 0 |
| 2014 | Economic burden of seasonal influenza B in France during winter 2010-2011 In: Post-Print. [Citation analysis] | paper | 1 |
| 2012 | Economic burden of seasonal influenza B in France during winter 2010-2011.(2012) In: Post-Print. [Citation analysis] This paper has another version. Agregated cites: 1 | paper | |
| 2013 | Economic burden of seasonal influenza B in France during winter 2010-2011.(2013) In: Post-Print. [Citation analysis] This paper has another version. Agregated cites: 1 | paper | |
| 2014 | Les fortes expositions aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) sont-elles lapanage des emplois précaires et peu qualifiés ? In: Post-Print. [Citation analysis] | paper | 0 |
| 2013 | Inégalités de lexposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel : SUMER 2010 In: Post-Print. [Citation analysis] | paper | 0 |
| 2009 | Costs and compliance with clinical practice guidelines: A pilot study for initial sarcoma treatment In: Post-Print. [Citation analysis] | paper | 0 |
| 2014 | Cost-effectiveness of a Genetic Test for Breast Cancer Risk - Letter In: Post-Print. [Citation analysis] | paper | 0 |
| 2014 | Inégalités de l’exposition aux produits chimiques cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel : les enseignements de l’enquête SUMER In: Post-Print. [Citation analysis] | paper | 0 |
| 2014 | Inégalités de lexposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel en France In: Post-Print. [Citation analysis] | paper | 0 |
| 2014 | Transferability of health cost evaluation across locations in oncology: cluster and principal component analysis as an explorative tool In: Post-Print. [Citation analysis] | paper | 0 |
| 2015 | Relationship between the development of electronic health records and hospital accreditation decisions in France: results from the E-SI (Preps-Sips) In: Post-Print. [Citation analysis] | paper | 0 |
| 2015 | Health Information System Adoption And Hospital Accreditation Decisions In France: Results From The E-SI (PREPS-SIPS) Study In: Post-Print. [Citation analysis] | paper | 0 |
| 2015 | A cost-consequence analysis of hepatitis B screening in an immigrant population In: Post-Print. [Citation analysis] | paper | 0 |
| 2016 | Impact of Electronic Health Records on the Hospital Bed Occupancy Rates in Surgical Units in France: Results from the E-SI (PREPS-SIPS) Study In: Post-Print. [Citation analysis] | paper | 0 |
| 2015 | Impact of Electronic Health Records on the Hospital Bed Occupancy Rates in Surgical Units in France: Results from the E-SI (PREPS-SIPS) Study.(2015) In: Post-Print. [Citation analysis] This paper has another version. Agregated cites: 0 | paper | |
| 2016 | A cost analysis of complex radiotherapy for patients with head and neck cancer In: Post-Print. [Citation analysis] | paper | 0 |
| 2016 | Système dinformation et performance hospitalière In: Post-Print. [Citation analysis] | paper | 0 |
| 2016 | Cost-Effectiveness Of Treatments For Mild-To-Moderate Obstructive Sleep Apnea In France In: Post-Print. [Full Text][Citation analysis] | paper | 0 |
| 2016 | Dossier Patient Informatisé : quel impact sur la performance des établissements de santé en France ? In: Post-Print. [Citation analysis] | paper | 0 |
| 2016 | Development of Seasonal Influenza Vaccination Recommendations: Relevance and Influence of the Evidence on the Decision-Making Process in France and the Netherlands In: Post-Print. [Citation analysis] | paper | 1 |
| 2016 | Toxicity and efficacy of cetuximab associated with several modalitiesof IMRT for locally advanced head and neck cancer In: Post-Print. [Citation analysis] | paper | 0 |
| 2016 | A cost-effectiveness analysis of the ZIRA test in breast cancer In: Post-Print. [Citation analysis] | paper | 0 |
| 2016 | Impact of health information systems on hospital bed occupancy rates in French hospitals: results from the e-SI (PREPS-SIPS) study In: Post-Print. [Citation analysis] | paper | 0 |
| 2016 | A cost-effectiveness analysis of a 6-month physical activity program versus usual dietary care during adjuvant chemotherapy in breast cancer: An economic evaluation of the PASAPAS trial In: Post-Print. [Citation analysis] | paper | 0 |
| 2017 | Percutaneous guided biopsy for diagnosing suspected primary malignant bone tumors in pediatric patients: a safe, accurate, and cost-saving procedure In: Post-Print. [Citation analysis] | paper | 0 |
| 2017 | Does adoption of electronic health records improve organizational performances of hospital surgical units? Results from the French e-SI (PREPS-SIPS) study In: Post-Print. [Citation analysis] | paper | 1 |
| 2016 | Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysis In: Post-Print. [Citation analysis] | paper | 0 |
| 2017 | In Reply to Escande et al In: Post-Print. [Citation analysis] | paper | 0 |
| 2016 | In Reply to Fodor and Di Muzio In: Post-Print. [Citation analysis] | paper | 0 |
| 2016 | Why should we focus on a structured model of secure digital exchanges to incorporate new documents in electronic patient records? In: Post-Print. [Citation analysis] | paper | 0 |
| 2016 | Is the Integrated Electronic Health Record Cost-Effective for a Cancer Consultation? Results from the E-SI (PREPS-SIPS) Study In: Post-Print. [Citation analysis] | paper | 0 |
| 2016 | General Practitioners Perceptions About Financial and Non-Financial Incentives to Improve Influenza Vaccination Coverage Rates In France In: Post-Print. [Citation analysis] | paper | 0 |
| 2016 | Cost Analysis of Human Genome Sequencing in Cancer Diagnosis in France: Next Generation Sequencing In: Post-Print. [Citation analysis] | paper | 0 |
| 2017 | Varied exposure to carcinogenic, mutagenic, and reprotoxic (CMR) chemicals in occupational settings in France In: Post-Print. [Citation analysis] | paper | 0 |
| 2016 | Guide méthodologique sur le costing à l’Hôpital In: Post-Print. [Citation analysis] | paper | 0 |
| 2017 | Trends in occupational disparities for exposure to carcinogenic, mutagenic and reprotoxic chemicals in France 2003–10 In: Post-Print. [Citation analysis] | paper | 0 |
| 2018 | Performance and cost evaluation of health information systems using micro-costing and discrete-event simulation In: Post-Print. [Citation analysis] | paper | 1 |
| 2017 | Assessment of a self-administered questionnaire identifying occupational exposures among lung cancer patients In: Post-Print. [Full Text][Citation analysis] | paper | 0 |
| 2017 | Radiotherapy costs: the good, the bad and the ugly In: Post-Print. [Citation analysis] | paper | 0 |
| 2017 | Analyse des corrélations entre informatisation et performance des établissements de santé In: Post-Print. [Citation analysis] | paper | 0 |
| 2017 | Management of Febrile Neutropenias in Adolescents and Young Adults: A Cost-Minimization Analysis Between Adult Versus Pediatric Units In: Post-Print. [Citation analysis] | paper | 0 |
| 2017 | Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score–Weighted Analysis In: Post-Print. [Citation analysis] | paper | 0 |
| 2017 | Does adoption of electronic health records improve the quality of care management in France? Results from the French e-SI (PREPS-SIPS) study In: Post-Print. [Citation analysis] | paper | 0 |
| 2017 | Guide méthodologique sur le calcul et l’analyse des coûts hospitaliers In: Post-Print. [Citation analysis] | paper | 0 |
| 2018 | In reply to Tallet et al. In: Post-Print. [Citation analysis] | paper | 0 |
| 2018 | In reply to Jean-François Daisne, Sandra Nuyts, Fréderic Duprez and Benoît Bihin In: Post-Print. [Citation analysis] | paper | 0 |
| 2017 | What Underlies The Observed Hospital Volume-Outcome Relationship? In: Post-Print. [Citation analysis] | paper | 0 |
| 2017 | Cost of radiotherapy: what is the quality of the evidence found? Critical quality appraisal of studies estimating cost of radiotherapy In: Post-Print. [Citation analysis] | paper | 0 |
| 2017 | Does adoption of electronic heath record improve the quality of care management? In: Post-Print. [Citation analysis] | paper | 0 |
| 2017 | Does adoption of electronic records improve organizational performances of hospital surgical units? In: Post-Print. [Citation analysis] | paper | 0 |
| 2018 | Being Treated In Higher Volume Hospitals Leads To Longer Progression-Free Survival For Epithelial Ovarian Carcinoma Patients in the Rhone-Alpes region of France In: Post-Print. [Full Text][Citation analysis] | paper | 3 |
| 2017 | Les impacts médico-économiques de lévolution du parcours de soins en cancérologie In: Post-Print. [Citation analysis] | paper | 0 |
| 2014 | Inégalités de lexposition aux produits cancérogènes, mutagènes ou reprotoxiques (CMR) en milieu professionnel : les enseignements de lenquête SUMER In: Working Papers. [Citation analysis] | paper | 0 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated August, 1st 2022. Contact: CitEc Team